EX-23.1 3 a18-41517_1ex23d1.htm EX-23.1

Exhibit 23.1

 

 

Tel:   732-750-0900

Fax:  732-750-1222

www.bdo.com

90 Woodbridge Center Drive
Woodbridge, NJ 07095

 

Consent of Independent Registered Public Accounting Firm

 

Eagle Pharmaceuticals, Inc.

Woodcliff Lake, New Jersey

 

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 of our reports dated February 26, 2018, relating to the consolidated financial statements, and the effectiveness of Eagle Pharmaceuticals, Inc.’s internal control over financial reporting, which appear in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017.

 

/s/ BDO USA, LLP

Woodbridge, New Jersey

 

December 18, 2018

(date of signing consent)

 

R-221 (6/14)